DOI: 10.1055/s-00000085

The Thoracic and Cardiovascular Surgeon

LinksClose Window

References

Wakelee HA, Stephenson P, Keller SM , et al. Eastern Cooperative Oncology Group.
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590.

Lung Cancer 2005;
48 (3) 389-397

Download Bibliographical Data

Search in:
Access:
Access:

We do not assume any responsibility for the contents of the web pages of other providers.